ArticleCureus2024
Proteinuria as a Critical Indicator of Kidney Dysfunction in Type 2 Diabetes Patients: Insights From a Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Kidney dysfunction is a common finding among patients with diabetes mellitus. We sought to determine the prevalence and contributors to kidney dysfunction among type 2 diabetes mellitus (T2D) patients. Methods In this descriptive and analytical cross-sectional study, we received consent and enrolled 148 T2D patients attending the diabetic clinic of Soroti Regional Referral Hospital in eastern Uganda from May 2023 to July 2023. We used questionnaires to obtain participants' socio-demographic and behavioral characteristics. Blood and urine samples were collected and analyzed for kidney dysfunction and other metabolic biomarkers, which included serum glucose, creatinine, estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), uric acid, triglycerides, total cholesterol, low and high-density lipoprotein cholesterol, and urinalysis. We performed blood tests using an automated chemistry analyzer. Results Of the 148 participants with T2D, 71 (47.97%) had kidney dysfunction (95% CI: 39.98-56.07). Bivariate and multivariate logistic regression analysis revealed only total proteinuria (OR 1.046; 95% CI: 1.014-1.079; P = 0.004) as a significant factor contributing to the observed kidney dysfunction in T2D patients. Conclusion Kidney dysfunction is a common occurrence among T2D patients in our study setting. The presence of proteins in urine contributes immensely to the observed kidney status in our study population. Total proteinuria should be frequently screened in the routine care of T2D patients in eastern Uganda to curb kidney dysfunction at an early stage. Also, a larger study is recommended to validate these findings and inform screening programs in the study area.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.